Dáil Éireann Debate, Wednesday - 27 May 2026
257. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure under the treatment abroad scheme in each year since 2020; the number of approved patients in each year; and the average approved expenditure per patient annually. [40614/26]
View answer258. Deputy Ken O'Flynn asked the Minister for Health whether expenditure and activity data reviewed during quarterly treatment abroad scheme oversight meetings with the Department of Health is recorded in a standardised reporting format; and if she will provide copies of the reporting templates used. [40615/26]
View answer259. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme records activity data by clinical speciality, treatment category, age cohort or referral pathway; and if she will provide a breakdown of the categories currently recorded. [40616/26]
View answer261. Deputy Ken O'Flynn asked the Minister for Health whether any internal reports, dashboards, expenditure summaries or performance-monitoring documents relating to the treatment abroad scheme are routinely furnished to the Department of Health; and if she will provide details of the documents concerned. [40618/26]
View answer262. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme maintains separate expenditure or activity reporting for referrals involving minors. [40619/26]
View answer263. Deputy Ken O'Flynn asked the Minister for Health the number of treatment abroad scheme applications submitted, approved, refused and withdrawn in each HSE health region in each year since 2020. [40620/26]
View answer264. Deputy Ken O'Flynn asked the Minister for Health whether any internal analysis has been conducted comparing treatment abroad scheme referral rates per capita across HSE health regions. [40621/26]
View answer265. Deputy Ken O'Flynn asked the Minister for Health whether any equality impact assessment or access equity review has been conducted in relation to regional variation in treatment abroad scheme utilisation. [40622/26]
View answer267. Deputy Ken O'Flynn asked the Minister for Health whether any approval-rate benchmarking exists between specialties, consultants or regions under the treatment abroad scheme. [40624/26]
View answer268. Deputy Ken O'Flynn asked the Minister for Health which officer or division holds responsibility for monitoring consistency of treatment abroad scheme decision-making nationally. [40625/26]
View answerI propose to take Questions Nos. 257 to 259, inclusive, 261 to 265, inclusive, 267 and 268 together.
As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
